Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q4 2023 Earnings Call Transcript

Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q4 2023 Earnings Call Transcript February 29, 2024

Lisata Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.66, expectations were $-0.86. LSTA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Welcome to the Lisata Therapeutics Full Year 2023 Financial Results and Business Update Conference Call. [Operator Instructions]. As a reminder, this call is being...